Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 1
2007 1
2008 4
2009 3
2010 6
2011 12
2012 13
2013 6
2014 8
2015 13
2016 13
2017 4
2018 1
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS. Herbst RS, et al. Among authors: kohrt he. Nature. 2014 Nov 27;515(7528):563-7. doi: 10.1038/nature14011. Nature. 2014. PMID: 25428504 Free PMC article. Clinical Trial.
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R. Chao MP, et al. Among authors: kohrt he. Cell. 2010 Sep 3;142(5):699-713. doi: 10.1016/j.cell.2010.07.044. Cell. 2010. PMID: 20813259 Free PMC article.
Rationale for anti-CD137 cancer immunotherapy.
Makkouk A, Chester C, Kohrt HE. Makkouk A, et al. Among authors: kohrt he. Eur J Cancer. 2016 Feb;54:112-119. doi: 10.1016/j.ejca.2015.09.026. Epub 2016 Jan 2. Eur J Cancer. 2016. PMID: 26751393 Review.
In situ vaccination for the treatment of cancer.
Hammerich L, Bhardwaj N, Kohrt HE, Brody JD. Hammerich L, et al. Among authors: kohrt he. Immunotherapy. 2016;8(3):315-30. doi: 10.2217/imt.15.120. Epub 2016 Feb 9. Immunotherapy. 2016. PMID: 26860335 Review.
Combination strategies to enhance antitumor ADCC.
Kohrt HE, Houot R, Marabelle A, Cho HJ, Osman K, Goldstein M, Levy R, Brody J. Kohrt HE, et al. Immunotherapy. 2012 May;4(5):511-27. doi: 10.2217/imt.12.38. Immunotherapy. 2012. PMID: 22642334 Free PMC article. Review.
Critical issues in cancer vaccine trial design.
Clifton GT, Kohrt HE, Peoples GE. Clifton GT, et al. Among authors: kohrt he. Vaccine. 2015 Dec 16;33(51):7386-7392. doi: 10.1016/j.vaccine.2015.09.019. Epub 2015 Sep 19. Vaccine. 2015. PMID: 26392010 Review.
Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.
Yonezawa A, Dutt S, Chester C, Kim J, Kohrt HE. Yonezawa A, et al. Among authors: kohrt he. Clin Cancer Res. 2015 Jul 15;21(14):3113-20. doi: 10.1158/1078-0432.CCR-15-0263. Epub 2015 Apr 23. Clin Cancer Res. 2015. PMID: 25908780 Free PMC article. Review.
Cancer vaccines and T cell therapy.
Rezvani K, Brody JD, Kohrt HE, Logan AC, Advani R, Czerwinski DK, Weng WK, Negrin RS, Carlton V, Faham M, Levy R, Barrett J. Rezvani K, et al. Among authors: kohrt he. Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S97-S101. doi: 10.1016/j.bbmt.2012.09.020. Epub 2012 Oct 3. Biol Blood Marrow Transplant. 2013. PMID: 23041602 Free PMC article. Review. No abstract available.
4-1BB agonism: adding the accelerator to cancer immunotherapy.
Chester C, Ambulkar S, Kohrt HE. Chester C, et al. Among authors: kohrt he. Cancer Immunol Immunother. 2016 Oct;65(10):1243-8. doi: 10.1007/s00262-016-1829-2. Epub 2016 Mar 31. Cancer Immunol Immunother. 2016. PMID: 27034234 Free PMC article. Review.
79 results